FDA Approves Biannual HIV Prevention Shot to Reduce Transmission
TL;DR Summary
The article details the decades-long journey of Gilead Sciences in developing lenacapavir, a groundbreaking HIV drug approved by the FDA that can be administered twice a year, offering a new hope for treatment and prevention, especially for resistant HIV strains and marginalized communities.
- The decades-long journey to Gilead’s twice-a-year HIV prevention drug lenacapavir STAT
- FDA approves twice-a-year injection for HIV prevention CNN
- The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it AP News
- FDA approves powerful HIV prevention drug: What to know about Yeztugo NBC News
- Regulators Approve a Twice-Yearly Shot to Prevent H.I.V. Infection The New York Times
Reading Insights
Total Reads
1
Unique Readers
3
Time Saved
31 min
vs 31 min read
Condensed
99%
6,196 → 43 words
Want the full story? Read the original article
Read on STAT